Kolkata-based McNally Bharat Engineering Co Ltd said it received orders, worth Rs33.77 crore, from NTPC Ltd for their Vindhyachal Super Thermal Power project.
The scope of the work includes supply under pre-treatment plant package and inland transportation, insurance, erection, testing, commissioning and guarantee tests of pre-treatment plant package for Vindhyachal project, stage IV (2x500 MW). The schedule time for completion is 24 months, the company said in a regulatory filing.
On Friday, McNally Bharat Engineering shares closed 5% higher at Rs57 on the Bombay Stock Exchange, while the Sensex ended at 1% up at 17,833 points.
Mumbai-based Pratibha Industries Ltd said its joint venture with Lucknow-based Abhyudaya Housing and Construction Pvt Ltd, has won an annuity project from National Highways Authority of India (NHAI). The total revenues receivable from NHAI is Rs336.70 crore, the company said in a regulatory filing.
The project involves two laning of Bhopal-Sanchi section of NH 86. The project is to be executed on built, operate and transfer (BOT) basis on design, build, finance and operate (DBFO) pattern under National Highways Development Project (NHDP) phase III. The construction period is two years and payments would be done through semi-annual annuities of Rs12.95 crore for 13 years totalling to Rs336.70 crore.
On Friday, Pratibha Industries shares closed 0.1% down at Rs409 on the Bombay Stock Exchange, while the Sensex ended at 1% up at 17,833 points.
Sharon Bio-Medicine Ltd said its formulation plant at Dehradun has been approved by UK-based Medicines and Health Care Product Regulatory Agency (MHRA).
The company, located in Raigad, Maharashtra, expect the sales to start in near future to the UK and Europe, Sharon Bio-Medicine said in a regulatory filing.
On Friday, Sharon Bio-Medicine shares closed 3.2% higher at Rs135 on the Bombay Stock Exchange, while the Sensex ended at 1% up at 17,833 points.